Ali Yazdanyar
Overview
Explore the profile of Ali Yazdanyar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
327
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Yazdanyar A, Donato A, Wasko M, Ward M
J Rheumatol
. 2022 Mar;
49(3):340.
PMID: 35232833
No abstract available.
12.
Lo K, Essa H, Wattoo A, Gulab A, Akhtar H, Sudani H, et al.
Curr Probl Cardiol
. 2021 Nov;
48(3):101047.
PMID: 34785259
Patients with advanced chronic kidney disease (CKD) have largely been excluded from randomized control trials (RCTs) in heart failure (HF). This creates a paucity of high quality evidence for guideline...
13.
Yazdanyar A, Donato A, Wasko M, Ward M
J Rheumatol
. 2021 Oct;
49(2):205-212.
PMID: 34599044
Objective: To determine the indication and risk of 30-day rehospitalization after hip or knee replacement among patients with rheumatoid arthritis (RA) and osteoarthritis (OA) by Medicare and non-Medicare status. Methods:...
14.
Yazdanyar A, Lo K, Pelayo J, Sanon J, Romero A, Quintero E, et al.
Curr Probl Cardiol
. 2021 Sep;
47(10):100993.
PMID: 34571101
There are limited data on clinical outcomes in patients re-admitted with decompensated heart failure (HF) with concomitant liver cirrhosis. We conducted a cross sectional analysis of the Nationwide Readmissions Database...
15.
Yazdanyar A, Maqsood M, Pelayo J, Sanon J, Quintero E, Lo K, et al.
Rev Cardiovasc Med
. 2021 Sep;
22(3):925-929.
PMID: 34565092
Outcomes of heart failure (HF) hospitalization are driven by the presence or absence of comorbid conditions. Cirrhosis is associated with worse outcomes in patients with HF, and both HF and...
16.
Yazdanyar A, Sanon J, Lo K, Joshi A, Kurtz E, Saqib M, et al.
Am J Cardiol
. 2020 Dec;
142:97-102.
PMID: 33285095
Acute heart failure (HF) management is a complex and often involves a delicate balance of both cardiac and renal systems. Although pharmacologic diuresis is a mainstay of the pharmacologic management...
17.
Beauchamp G, Laubach L, Esposito S, Yazdanyar A, Roth P, Lauber P, et al.
J Med Toxicol
. 2020 Nov;
17(2):176-184.
PMID: 33146875
Introduction: Implementing a hospital medication for addiction treatment (MAT) and a linkage program can improve care for patients with substance use disorder (SUD); however, lack of hospital funding and brick...
18.
Beauchamp G, Rosentel J, Yazdanyar A, Farber E, Levi J, Laubach L, et al.
Am J Emerg Med
. 2020 Jun;
41:247-250.
PMID: 32534875
No abstract available.
19.
Yazdanyar A, Aziz M, Enright P, Edmundowicz D, Boudreau R, Sutton-Tyrell K, et al.
J Aging Health
. 2014 Apr;
26(4):583-599.
PMID: 24695552
Objective: To examine the association between 6-min walk test (6 MWT) performance and all-cause mortality, coronary heart disease mortality, and incident coronary heart disease in older adults. Method: We conducted...
20.
Yazdanyar A, Wasko M, Scalzi L, Kraemer K, Ward M
Arthritis Care Res (Hoboken)
. 2012 Dec;
65(6):986-91.
PMID: 23213026
Objective: Persons with systemic lupus erythematosus (SLE) are at an increased risk of cardiovascular disease (CVD) events, but this excess CVD burden in the perioperative setting is yet to be...